Acute valve syndrome (AVS) plus delayed aortic valve replacement (AVR) is associated with a higher risk of death, stroke or heart failure hospitalization (HFH) in patients with severe aortic stenosis (AS) within 2 years after the procedure, compared with early transcatheter aortic valve replacement (TAVR), a sub-analysis of the EARLY-TAVR trial shows.